Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Object Symbol | Species | Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | C13h1orf115 | Rat | (+)-schisandrin B | multiple interactions | EXP | | 6480464 | schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of C13H1ORF115 mRNA] | CTD | PMID:31150632 | C13h1orf115 | Rat | 1,1,1-trichloro-2,2-bis(4-hydroxyphenyl)ethane | multiple interactions | EXP | | 6480464 | 2,2-bis(4-hydroxyphenyl)-1,1,1-trichloroethane affects the reaction [Cyclic AMP affects the expression of C13H1ORF115 mRNA]; 2,2-bis(4-hydroxyphenyl)-1,1,1-trichloroethane affects the more ... | CTD | PMID:19414516 | C13h1orf115 | Rat | 17beta-estradiol | multiple interactions | ISO | C1orf115 (Homo sapiens) | 6480464 | [Estradiol co-treated with TGFB1 protein] results in decreased expression of C1ORF115 mRNA | CTD | PMID:30165855 | C13h1orf115 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | EXP | | 6480464 | Tetrachlorodibenzodioxin affects the expression of C13H1ORF115 mRNA | CTD | PMID:32109520|PMID:34747641 | C13h1orf115 | Rat | 3',5'-cyclic AMP | multiple interactions | EXP | | 6480464 | 2,2-bis(4-hydroxyphenyl)-1,1,1-trichloroethane affects the reaction [Cyclic AMP affects the expression of C13H1ORF115 mRNA] | CTD | PMID:19414516 | C13h1orf115 | Rat | 4,4'-sulfonyldiphenol | decreases expression | ISO | C1orf115 (Homo sapiens) | 6480464 | bisphenol S results in decreased expression of C1ORF115 mRNA | CTD | PMID:25912373 | C13h1orf115 | Rat | 6-propyl-2-thiouracil | decreases expression | EXP | | 6480464 | Propylthiouracil results in decreased expression of C13H1ORF115 mRNA | CTD | PMID:24780913 | C13h1orf115 | Rat | acrylamide | decreases expression | EXP | | 6480464 | Acrylamide results in decreased expression of C13H1ORF115 mRNA | CTD | PMID:28959563 | C13h1orf115 | Rat | acrylamide | decreases expression | ISO | C1orf115 (Homo sapiens) | 6480464 | Acrylamide results in decreased expression of C1ORF115 mRNA | CTD | PMID:32763439 | C13h1orf115 | Rat | aflatoxin B1 | decreases expression | ISO | C1orf115 (Homo sapiens) | 6480464 | Aflatoxin B1 results in decreased expression of C1ORF115 mRNA | CTD | PMID:27153756 | C13h1orf115 | Rat | atrazine | increases expression | ISO | C1orf115 (Homo sapiens) | 6480464 | Atrazine results in increased expression of C1ORF115 mRNA | CTD | PMID:22378314 | C13h1orf115 | Rat | benzo[a]pyrene | decreases expression | ISO | C1orf115 (Homo sapiens) | 6480464 | Benzo(a)pyrene results in decreased expression of C1ORF115 mRNA | CTD | PMID:32234424 | C13h1orf115 | Rat | bisphenol A | decreases expression | EXP | | 6480464 | bisphenol A results in decreased expression of C13H1ORF115 mRNA; bisphenol A results in decreased expression more ... | CTD | PMID:25181051|PMID:30816183|PMID:32528016|PMID:34947998|PMID:38750585 | C13h1orf115 | Rat | bisphenol A | affects expression | ISO | C1orf115 (Homo sapiens) | 6480464 | bisphenol A affects the expression of C1ORF115 mRNA | CTD | PMID:30903817 | C13h1orf115 | Rat | bisphenol A | decreases expression | ISO | C1orf115 (Homo sapiens) | 6480464 | bisphenol A results in decreased expression of C1ORF115 mRNA | CTD | PMID:27685785 | C13h1orf115 | Rat | bisphenol AF | decreases expression | ISO | C1orf115 (Homo sapiens) | 6480464 | bisphenol AF results in decreased expression of C1ORF115 mRNA | CTD | PMID:25912373 | C13h1orf115 | Rat | cadmium dichloride | increases expression | ISO | C1orf115 (Homo sapiens) | 6480464 | Cadmium Chloride results in increased expression of C1ORF115 mRNA | CTD | PMID:38174414 | C13h1orf115 | Rat | cisplatin | decreases expression | ISO | C1orf115 (Homo sapiens) | 6480464 | Cisplatin results in decreased expression of C1ORF115 mRNA | CTD | PMID:27392435 | C13h1orf115 | Rat | copper(II) sulfate | decreases expression | ISO | C1orf115 (Homo sapiens) | 6480464 | Copper Sulfate results in decreased expression of C1ORF115 mRNA | CTD | PMID:19549813 | C13h1orf115 | Rat | coumestrol | decreases expression | ISO | C1orf115 (Homo sapiens) | 6480464 | Coumestrol results in decreased expression of C1ORF115 mRNA | CTD | PMID:19167446 | C13h1orf115 | Rat | coumestrol | multiple interactions | ISO | C1orf115 (Homo sapiens) | 6480464 | [Coumestrol co-treated with resveratrol] results in decreased expression of C1ORF115 mRNA | CTD | PMID:19167446 | C13h1orf115 | Rat | cyclosporin A | decreases expression | ISO | C1orf115 (Homo sapiens) | 6480464 | Cyclosporine results in decreased expression of C1ORF115 mRNA | CTD | PMID:20106945|PMID:25562108 | C13h1orf115 | Rat | Dibutyl phosphate | affects expression | ISO | C1orf115 (Homo sapiens) | 6480464 | di-n-butylphosphoric acid affects the expression of C1ORF115 mRNA | CTD | PMID:37042841 | C13h1orf115 | Rat | dorsomorphin | multiple interactions | ISO | C1orf115 (Homo sapiens) | 6480464 | [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased more ... | CTD | PMID:27188386 | C13h1orf115 | Rat | endosulfan | decreases expression | EXP | | 6480464 | Endosulfan results in decreased expression of C13H1ORF115 mRNA | CTD | PMID:29391264 | C13h1orf115 | Rat | flutamide | decreases expression | EXP | | 6480464 | Flutamide results in decreased expression of C13H1ORF115 mRNA | CTD | PMID:24136188 | C13h1orf115 | Rat | folic acid | decreases expression | ISO | C1orf115 (Homo sapiens) | 6480464 | Folic Acid results in decreased expression of C1ORF115 mRNA | CTD | PMID:21867686 | C13h1orf115 | Rat | gentamycin | increases expression | EXP | | 6480464 | Gentamicins results in increased expression of C13H1ORF115 mRNA | CTD | PMID:33387578 | C13h1orf115 | Rat | lead(0) | affects expression | ISO | C1orf115 (Homo sapiens) | 6480464 | Lead affects the expression of C1ORF115 mRNA | CTD | PMID:28903495 | C13h1orf115 | Rat | N-methyl-4-phenylpyridinium | increases expression | ISO | C1orf115 (Homo sapiens) | 6480464 | 1-Methyl-4-phenylpyridinium results in increased expression of C1ORF115 mRNA | CTD | PMID:24810058 | C13h1orf115 | Rat | nefazodone | decreases expression | EXP | | 6480464 | nefazodone results in decreased expression of C13H1ORF115 mRNA | CTD | PMID:24136188 | C13h1orf115 | Rat | nickel atom | decreases expression | ISO | C1orf115 (Homo sapiens) | 6480464 | Nickel results in decreased expression of C1ORF115 mRNA | CTD | PMID:24768652|PMID:25583101 | C13h1orf115 | Rat | oxaliplatin | multiple interactions | EXP | | 6480464 | [Oxaliplatin co-treated with Topotecan] results in increased expression of C13H1ORF115 mRNA | CTD | PMID:25729387 | C13h1orf115 | Rat | paracetamol | decreases expression | ISO | C1orf115 (Homo sapiens) | 6480464 | Acetaminophen results in decreased expression of C1ORF115 mRNA | CTD | PMID:29067470 | C13h1orf115 | Rat | perfluorooctanoic acid | multiple interactions | ISO | C1orf115 (Homo sapiens) | 6480464 | [Plasticizers co-treated with Cosmetics co-treated with Flame Retardants co-treated with perfluorooctanoic acid co-treated with Phytoestrogens] more ... | CTD | PMID:33325755 | C13h1orf115 | Rat | phenylmercury acetate | decreases expression | ISO | C1orf115 (Homo sapiens) | 6480464 | Phenylmercuric Acetate results in decreased expression of C1ORF115 mRNA | CTD | PMID:26272509 | C13h1orf115 | Rat | phenylmercury acetate | multiple interactions | ISO | C1orf115 (Homo sapiens) | 6480464 | [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased more ... | CTD | PMID:27188386 | C13h1orf115 | Rat | phytoestrogen | multiple interactions | ISO | C1orf115 (Homo sapiens) | 6480464 | [Plasticizers co-treated with Cosmetics co-treated with Flame Retardants co-treated with perfluorooctanoic acid co-treated with Phytoestrogens] more ... | CTD | PMID:33325755 | C13h1orf115 | Rat | quercetin | increases expression | EXP | | 6480464 | Quercetin results in increased expression of C13H1ORF115 mRNA | CTD | PMID:21565894 | C13h1orf115 | Rat | quercetin | decreases expression | ISO | C1orf115 (Homo sapiens) | 6480464 | Quercetin results in decreased expression of C1ORF115 mRNA | CTD | PMID:21632981 | C13h1orf115 | Rat | resveratrol | multiple interactions | ISO | C1orf115 (Homo sapiens) | 6480464 | [Coumestrol co-treated with resveratrol] results in decreased expression of C1ORF115 mRNA | CTD | PMID:19167446 | C13h1orf115 | Rat | SB 431542 | multiple interactions | ISO | C1orf115 (Homo sapiens) | 6480464 | [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased more ... | CTD | PMID:27188386 | C13h1orf115 | Rat | silicon dioxide | decreases expression | ISO | C1orf115 (Homo sapiens) | 6480464 | Silicon Dioxide analog results in decreased expression of C1ORF115 mRNA | CTD | PMID:25895662 | C13h1orf115 | Rat | silicon dioxide | increases expression | ISO | C1orf115 (Homo sapiens) | 6480464 | Silicon Dioxide results in increased expression of C1ORF115 mRNA | CTD | PMID:25351596 | C13h1orf115 | Rat | sulforaphane | decreases expression | ISO | C1orf115 (Homo sapiens) | 6480464 | sulforaphane results in decreased expression of C1ORF115 mRNA | CTD | PMID:31838189 | C13h1orf115 | Rat | tert-butyl hydroperoxide | decreases expression | ISO | C1orf115 (Homo sapiens) | 6480464 | tert-Butylhydroperoxide results in decreased expression of C1ORF115 mRNA | CTD | PMID:15336504 | C13h1orf115 | Rat | testosterone | decreases expression | ISO | C1orf115 (Homo sapiens) | 6480464 | Testosterone results in decreased expression of C1ORF115 mRNA | CTD | PMID:33359661 | C13h1orf115 | Rat | tetrachloromethane | decreases expression | EXP | | 6480464 | Carbon Tetrachloride results in decreased expression of C13H1ORF115 mRNA | CTD | PMID:31150632 | C13h1orf115 | Rat | tetrachloromethane | multiple interactions | EXP | | 6480464 | schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of C13H1ORF115 mRNA] | CTD | PMID:31150632 | C13h1orf115 | Rat | thimerosal | decreases expression | ISO | C1orf115 (Homo sapiens) | 6480464 | Thimerosal results in decreased expression of C1ORF115 mRNA | CTD | PMID:27188386 | C13h1orf115 | Rat | thioacetamide | decreases expression | EXP | | 6480464 | Thioacetamide results in decreased expression of C13H1ORF115 mRNA | CTD | PMID:34492290 | C13h1orf115 | Rat | thiram | increases expression | ISO | C1orf115 (Homo sapiens) | 6480464 | Thiram results in increased expression of C1ORF115 mRNA | CTD | PMID:38568856 | C13h1orf115 | Rat | topotecan | multiple interactions | EXP | | 6480464 | [Oxaliplatin co-treated with Topotecan] results in increased expression of C13H1ORF115 mRNA | CTD | PMID:25729387 | C13h1orf115 | Rat | trichloroethene | decreases expression | EXP | | 6480464 | Trichloroethylene results in decreased expression of C13H1ORF115 mRNA | CTD | PMID:33387578 | C13h1orf115 | Rat | triphenyl phosphate | affects expression | ISO | C1orf115 (Homo sapiens) | 6480464 | triphenyl phosphate affects the expression of C1ORF115 mRNA | CTD | PMID:37042841 | C13h1orf115 | Rat | valproic acid | affects expression | ISO | C1orf115 (Homo sapiens) | 6480464 | Valproic Acid affects the expression of C1ORF115 mRNA | CTD | PMID:25979313 | C13h1orf115 | Rat | valproic acid | increases expression | ISO | C1orf115 (Homo sapiens) | 6480464 | Valproic Acid results in increased expression of C1ORF115 mRNA | CTD | PMID:19101580|PMID:23179753|PMID:27188386|PMID:28001369 | C13h1orf115 | Rat | vinclozolin | affects expression | EXP | | 6480464 | vinclozolin affects the expression of C13H1ORF115 mRNA | CTD | PMID:19015723 | C13h1orf115 | Rat | vinclozolin | decreases expression | EXP | | 6480464 | vinclozolin results in decreased expression of C13H1ORF115 mRNA | CTD | PMID:22615374 | | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||






















